Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine the differential effect of ezetimibe on MACEs when added to statins according to the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Metab (Seoul)
Main Authors: Hong, Namki, Lee, Yong-ho, Tsujita, Kenichi, Gonzalez, Jorge A., Kramer, Christopher M., Kovarnik, Tomas, Kouvelos, George N., Suzuki, Hiromichi, Han, Kyungdo, Lee, Chan Joo, Park, Sung Ha, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Endocrine Society 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021322/
https://ncbi.nlm.nih.gov/pubmed/29766679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2018.33.2.219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados